Date Filed | Type | Description |
05/12/2023 |
4
| Tyree James L (Director) has filed a Form 4 on Assertio Holdings, Inc.
Txns:
| Granted 31,194 shares
@ $0 Granted 3,821 options to buy
@ $7.55, valued at
$28.8k
|
|
05/05/2023 |
4
| Tyree James L (Director) has filed a Form 4 on Assertio Holdings, Inc.
Txns:
| Sold 43,143 shares
@ $5.9979, valued at
$258.8k
|
|
05/05/2023 |
144
| Form 144 - Report of proposed sale of securities: |
05/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/25/2023 |
3
| Tyree James L (Director) has filed a Form 3 on GENELUX CORP |
10/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/31/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/16/2022 |
4
| Tyree James L (Director) has filed a Form 4 on Assertio Holdings, Inc.
Txns:
| Sold 44,643 shares
@ $2.3558, valued at
$105.2k
|
|
05/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/21/2021 |
4
| Tyree James L (Director) has filed a Form 4 on ChemoCentryx, Inc.
Txns:
| Sold 2,800 shares
@ $33.52, valued at
$93.9k
Sold 16,634 shares
@ $34.7417, valued at
$577.9k
Sold 18,066 shares
@ $35.504, valued at
$641.4k
Exercised 25,000 options to buy
@ $12.62, valued at
$315.5k
Exercised 12,500 options to buy
@ $14.42, valued at
$180.3k
|
|
05/24/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/26/2020 |
4
| Tyree James L (Director) has filed a Form 4 on ChemoCentryx, Inc.
Txns:
| Granted 2,888 options to buy
@ $59.73, valued at
$172.5k
Granted 4,660 restricted stock units
@ $0 Exercised 7,724 restricted stock units
@ $0 |
|
05/21/2020 |
4
| Tyree James L (Director) has filed a Form 4 on Assertio Holdings, Inc.
Txns:
| Granted 237,500 shares
@ $0 |
|
01/15/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/23/2019 |
4
| Tyree James L (Director) has filed a Form 4 on ChemoCentryx, Inc.
Txns:
| Exercised 8,421 restricted stock units
@ $0 Granted 7,724 restricted stock units
@ $0 Granted 12,287 options to buy
@ $11.6, valued at
$142.5k
|
|
05/09/2019 |
4
| Tyree James L (Director) has filed a Form 4 on Assertio Therapeutics, Inc
Txns:
| Granted 39,584 shares
@ $0 Exercised 31,250 restricted stock units
@ $0 |
|
02/14/2019 |
5
| Form 5 - Annual statement of changes in beneficial ownership of securities: |
05/23/2018 |
4
| Tyree James L (Director) has filed a Form 4 on ChemoCentryx, Inc.
Txns:
| Granted 8,421 restricted stock units
@ $0 Granted 13,352 options to buy
@ $12.94, valued at
$172.8k
|
|
05/10/2018 |
4
| Tyree James L (Director) has filed a Form 4 on DEPOMED INC
Txns:
| Granted 31,250 options to buy
@ $0 |
|
08/16/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/10/2017 |
144
| Form 144 - Report of proposed sale of securities: |
05/30/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
04/24/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
10/19/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
10/19/2016 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
05/27/2016 |
4
| Tyree James L (Director) has filed a Form 4 on ChemoCentryx, Inc.
Txns:
| Granted 20,362 restricted stock units
@ $0 |
|
05/24/2016 |
4
| Tyree James L (Director) has filed a Form 4 on ChemoCentryx, Inc.
Txns:
| Sold 5,544 shares
@ $4.3898, valued at
$24.3k
Exercised 11,795 restricted stock units
@ $0 |
|
05/20/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
04/27/2016 |
4
| Tyree James L (Director) has filed a Form 4 on Innoviva, Inc.
Txns:
| Granted 18,328 shares
@ $0 |
|
05/28/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|